These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 23140912)

  • 1. Confirming glycemic status in the Diabetes Prevention Program: implications for diagnosing diabetes in high risk adults.
    Christophi CA; Resnick HE; Ratner RE; Temprosa M; Fowler S; Knowler WC; Shamoon H; Barrett-Connor E; Kahn SE;
    J Diabetes Complications; 2013; 27(2):150-7. PubMed ID: 23140912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between fasting plasma glucose and glycosylated hemoglobin: potential for false-positive diagnoses of type 2 diabetes using new diagnostic criteria.
    Davidson MB; Schriger DL; Peters AL; Lorber B
    JAMA; 1999 Apr; 281(13):1203-10. PubMed ID: 10199430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HbA1c measurement improves the detection of type 2 diabetes in high-risk individuals with nondiagnostic levels of fasting plasma glucose: the Early Diabetes Intervention Program (EDIP).
    Perry RC; Shankar RR; Fineberg N; McGill J; Baron AD;
    Diabetes Care; 2001 Mar; 24(3):465-71. PubMed ID: 11289469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined use of fasting plasma glucose and glycated hemoglobin A1c in the screening of diabetes and impaired glucose tolerance.
    Hu Y; Liu W; Chen Y; Zhang M; Wang L; Zhou H; Wu P; Teng X; Dong Y; Zhou Jw; Xu H; Zheng J; Li S; Tao T; Hu Y; Jia Y
    Acta Diabetol; 2010 Sep; 47(3):231-6. PubMed ID: 19760291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of diagnostic utility of fasting plasma glucose and HbA1c in stable renal transplant recipients one year after transplantation.
    Ussif AM; Åsberg A; Halden TAS; Nordheim E; Hartmann A; Jenssen T
    BMC Nephrol; 2019 Jan; 20(1):12. PubMed ID: 30630438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implications of the Hemoglobin Glycation Index on the Diagnosis of Prediabetes and Diabetes.
    Hsia DS; Rasouli N; Pittas AG; Lary CW; Peters A; Lewis MR; Kashyap SR; Johnson KC; LeBlanc ES; Phillips LS; Hempe JM; Desouza CV;
    J Clin Endocrinol Metab; 2020 Mar; 105(3):e130-8. PubMed ID: 31965161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus.
    Kuzuya T; Nakagawa S; Satoh J; Kanazawa Y; Iwamoto Y; Kobayashi M; Nanjo K; Sasaki A; Seino Y; Ito C; Shima K; Nonaka K; Kadowaki T;
    Diabetes Res Clin Pract; 2002 Jan; 55(1):65-85. PubMed ID: 11755481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of performance of A1c and FPG tests for screening newly diagnosed diabetes defined by an OGTT among tuberculosis patients-a study from India.
    Kumpatla S; Aravindalochanan V; Rajan R; Viswanathan V; Kapur A
    Diabetes Res Clin Pract; 2013 Oct; 102(1):60-4. PubMed ID: 24035281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood glucose patterns in type 2 diabetic patients with optimal fasting plasma glucose but high HbA1c.
    Charoenhirunyingyos W; Nitiyanant W; Thabsang P; Sriussadaporn S; Vannasaeng S
    J Med Assoc Thai; 2011 Mar; 94(3):278-85. PubMed ID: 21560834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using HbA(1c) to improve efficacy of the american diabetes association fasting plasma glucose criterion in screening for new type 2 diabetes in American Indians: the strong heart study.
    Wang W; Lee ET; Fabsitz R; Welty TK; Howard BV
    Diabetes Care; 2002 Aug; 25(8):1365-70. PubMed ID: 12145236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fasting plasma glucose and glycated haemoglobin in the screening of diabetes and impaired glucose tolerance.
    Mannucci E; Ognibene A; Sposato I; Brogi M; Gallori G; Bardini G; Cremasco F; Messeri G; Rotella CM
    Acta Diabetol; 2003 Dec; 40(4):181-6. PubMed ID: 14740278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fasting plasma glucose and glycosylated hemoglobin in the screening for diabetes mellitus after renal transplantation.
    Valderhaug TG; Jenssen T; Hartmann A; Midtvedt K; Holdaas H; Reisaeter AV; Hjelmesaeth J
    Transplantation; 2009 Aug; 88(3):429-34. PubMed ID: 19667949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined use of a fasting plasma glucose concentration and HbA1c or fructosamine predicts the likelihood of having diabetes in high-risk subjects.
    Ko GT; Chan JC; Yeung VT; Chow CC; Tsang LW; Li JK; So WY; Wai HP; Cockram CS
    Diabetes Care; 1998 Aug; 21(8):1221-5. PubMed ID: 9702423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnosing type 2 diabetes mellitus: in primary care, fasting plasma glucose and glycosylated haemoglobin do the job].
    Jimeno Mollet J; Molist Brunet N; Franch Nadal J; Morató Griera J; Otzet Gramunt I; Pons Barro P
    Aten Primaria; 2004 Sep; 34(5):222-8. PubMed ID: 15456566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive Value of Fasting Glucose, Postload Glucose, and Hemoglobin A
    Lu J; He J; Li M; Tang X; Hu R; Shi L; Su Q; Peng K; Xu M; Xu Y; Chen Y; Yu X; Yan L; Wang T; Zhao Z; Qin G; Wan Q; Chen G; Dai M; Zhang D; Gao Z; Wang G; Shen F; Luo Z; Qin Y; Chen L; Huo Y; Li Q; Ye Z; Zhang Y; Du R; Cheng D; Liu C; Wang Y; Wu S; Yang T; Deng H; Li D; Lai S; Bloomgarden ZT; Chen L; Zhao J; Mu Y; Ning G; Wang W; Bi Y;
    Diabetes Care; 2019 Aug; 42(8):1539-1548. PubMed ID: 31152120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycated hemoglobin independently or in combination with fasting plasma glucose versus oral glucose tolerance test to detect abnormal glycometabolism in acute ischemic stroke: a Chinese cross-sectional study.
    Wu S; Shi Y; Pan Y; Li J; Jia Q; Zhang N; Zhao X; Liu G; Wang Y; Wang Y; Wang C
    BMC Neurol; 2014 Sep; 14():177. PubMed ID: 25209629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A two-step strategy for identification of high-risk subjects for a clinical trial of prevention of NIDDM.
    Narayan KM; Hanson RL; Pettitt DJ; Bennett PH; Knowler WC
    Diabetes Care; 1996 Sep; 19(9):972-8. PubMed ID: 8875091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The simultaneous assessment of glycosylated hemoglobin, fasting plasma glucose and oral glucose tolerance test does not improve the detection of type 2 diabetes mellitus in Colombian adults.
    Lopez-Lopez J; Garay J; Wandurraga E; Camacho PA; Higuera-Escalante F; Cohen D; Lopez-Jaramillo P
    PLoS One; 2018; 13(4):e0194446. PubMed ID: 29652881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants of diagnostic discordance for non-diabetic hyperglycaemia and Type 2 diabetes using paired glycated haemoglobin measurements in a large English primary care population: cross-sectional study.
    Bachmann MO; Lewis G; John WG; Turner J; Dhatariya K; Clark A; Pascale M; Sampson M;
    Diabet Med; 2019 Nov; 36(11):1478-1486. PubMed ID: 31420897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fasting glucose, HbA1c, or oral glucose tolerance testing for the detection of glucose abnormalities in patients with acute coronary syndromes.
    Hage C; Lundman P; Rydén L; Mellbin L
    Eur J Prev Cardiol; 2013 Aug; 20(4):549-54. PubMed ID: 22456695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.